Regulatory Sourcebook eBook
Read the article:
Considering Titanium Dioxide Regulatory Changes
Read the eBook:
Pharmaceutical Technology’s Regulatory Sourcebook eBook.
EFSA’s evaluation of risk in food products raises implications for drug product formulations.
Titanium dioxide is widely used for adding opacity and brightness in many products. A May 2021 evaluation from the European Food Safety Authority (EFSA), which declared that titanium dioxide is unsafe for food products, alarmed other industries that rely on the ingredient. Although changes are not required in pharmaceutical products, some supplement and drug manufacturers and their suppliers have considered potential alternatives.
Read the article:
Considering Titanium Dioxide Regulatory Changes
Read the eBook:
Pharmaceutical Technology’s Regulatory Sourcebook eBook.
Pharmaceutical Technology
eBook: Regulatory Sourcebook
September 2021
Pages: 8-9
When referring to this article, please cite it as J. Markarian, “Considering Titanium Dioxide Regulatory Changes,” Pharmaceutical Technology Regulatory Sourcebook eBook (September 2021).
about 4 years ago
Understanding Combination Product Regulationsabout 4 years ago
The Real Danger of Substandard and Counterfeit COVID-19 Vaccinesabout 4 years ago
Changing the Course of Drug Shortagesabout 4 years ago
Industry Organizations Assist Pharma During the Pandemic and Beyondabout 4 years ago
Mapping Out Pharma’s Regulatory Future in EuropeGet the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.